Xinling Zhang

Dr. Xinling Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2023 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
PJPeijun Jia
Peijun Jia
JWJunmin Wang
Junmin Wang
XRXiuhua Ren
Xiuhua Ren
JHJinxin He
Jinxin He
SWShaoshuai Wang
Shaoshuai Wang
JWJian Wang
Jian Wang
Post-stroke depression exacerbates neurologic deficits and quality of life. Depression after ischemic stroke is known to some extent. However, depression after intracerebral hemorrhage (ICH) is relatively unknown. Increasing evidence shows that exposure to an enriched environment (EE) after cerebral ischemia/reperfusion injury has neuroprotective effects in animal models, but its impact after ICH is unknown. In this study, we investigated the effect of EE on long-term functional outcomes in mice subjected to collagenase-induced striatal ICH. Mice were subjected to ICH with the standard environment (SE) or ICH with EE for 6 h/day (8:00 am–2:00 pm). Depressive, anxiety-like behaviors and cognitive tests were evaluated on day 28 with the sucrose preference test, tail suspension test, forced swim test, light-dark transition experiment, morris water maze, and novel object recognition test. Exposure to EE improved neurologic function, attenuated depressive and anxiety-like behaviors, and promoted spatial learning and memory. These changes were associated with increased expression of transcription factor Nrf2 and brain-derived neurotrophic factor (BDNF) and inhibited glutaminase activity in the perihematomal tissue. However, EE did not change the above behavioral outcomes in Nrf2−/− mice on day 28. Furthermore, exposure to EE did not increase BDNF expression compared to exposure to SE in Nrf2−/− mice on day 28 after ICH. These findings indicate that EE improves long-term outcomes in sensorimotor, emotional, and cognitive behavior after ICH and that the underlying mechanism involves the Nrf2/BDNF/glutaminase pathway.

24 May 2021 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
MZMan Zhang
Man Zhang
XLXin Lin
Xin Lin
ZZZhijuan Zheng
Zhijuan Zheng
YCYing Chen
Ying Chen
YRYong Ren
Yong Ren
XZXinling Zhang
Xinling Zhang

22 August 2022 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
MWManli Wu
Manli Wu
MZMan Zhang
Man Zhang
JCJunyan Cao
Junyan Cao
SWShuangyu Wu
Shuangyu Wu
YCYing Chen
Ying Chen
XZXinling Zhang
Xinling Zhang

7 April 2023 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
JXJing Xu
Jing Xu
ZHZeping Huang
Zeping Huang
JZJie Zeng
Jie Zeng
ZZZhijuan Zheng
Zhijuan Zheng
JCJunyan Cao
Junyan Cao
XZXinling Zhang
Xinling Zhang

1 April 2022 in European Radiology
Verified
Journal Article
Closed access
PDF file
SWShuangyu Wu
Shuangyu Wu
YRYong Ren
Yong Ren
XLXin Lin
Xin Lin
ZHZeping Huang
Zeping Huang
ZZZhijuan Zheng
Zhijuan Zheng
XZXinling Zhang
Xinling Zhang

12 July 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JZJunlin Zhong
Junlin Zhong
MSManting Su
Manting Su
YJYe Jiang
Ye Jiang
LHLicong Huang
Licong Huang
YCYing Chen
Ying Chen
XZXinling Zhang
Xinling Zhang
Background: The current diagnostic methods of microinvasive cervical cancer lesions are imaging diagnosis and pathological evaluation. Pathological evaluation is invasive and imaging approaches are of extremely low diagnostic performance. There is a paucity of effective and noninvasive imaging approaches for these extremely early cervical cancer during clinical practice. In recent years, ultrasound molecular imaging (USMI) with vascular endothelial growth factor receptor type 2 (VEGFR2) targeted microbubble (MBVEGFR2) has been reported to improve the early diagnosis rates of breast cancer (including ductal carcinoma in situ), pancreatic cancer and hepatic micrometastases. Herein, we aimed to assess the feasibility of MBVEGFR2-based USMI in extremely early cervical cancer detection to provide an accurate imaging modality for microinvasive cervical cancer (International Federation of Gynecology and Obstetrics (FIGO) Stage IA1 and IA2). Results: We found MBVEGFR2-based USMI could successfully distinguish extremely early lesions in diameter < 3 mm from surrounding normal tissues (all P < 0.05), and the sensitivity gradually decreased along with increasing tumor diameter. Moreover, normalized intensity difference (NID) values showed a good linear correlation with microvessel density (MVD) (R2 = 0.75). In addition, all tumors could not be identified from surrounding muscles in subtracted ultrasound images when mice were administered MBCon. Conclusions: Overall, MBVEGFR2-based USMI has huge potential for clinical application for the early detection of microinvasive cervical cancer (FIGO Stage IA1 and IA2), providing the foothold for future studies on the imaging screening of this patient population.